Global Candesartan Cilexetil Tablets Market Growth 2025-2031

March 2025 | 134 pages | ID: G8BBEC181073EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global Candesartan Cilexetil Tablets market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

United States market for Candesartan Cilexetil Tablets is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Candesartan Cilexetil Tablets is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Candesartan Cilexetil Tablets is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Candesartan Cilexetil Tablets players cover Takeda, Viatris (Mylan), Apotex, AstraZeneca, Alembic Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Candesartan Cilexetil Tablets Industry Forecast” looks at past sales and reviews total world Candesartan Cilexetil Tablets sales in 2024, providing a comprehensive analysis by region and market sector of projected Candesartan Cilexetil Tablets sales for 2025 through 2031. With Candesartan Cilexetil Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Candesartan Cilexetil Tablets industry.

This Insight Report provides a comprehensive analysis of the global Candesartan Cilexetil Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Candesartan Cilexetil Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Candesartan Cilexetil Tablets market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Candesartan Cilexetil Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Candesartan Cilexetil Tablets.

This report presents a comprehensive overview, market shares, and growth opportunities of Candesartan Cilexetil Tablets market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• 4mg Tablets
• 8mg Tablets
• 16mg Tablets
• 32mg Tablets
• Others

Segmentation by Application:

• Essential Hypertension
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Takeda
• Viatris (Mylan)
• Apotex
• AstraZeneca
• Alembic Pharmaceuticals
• Zydus Lifesciences
• Cheplapharm Arzneimittel
• ANI Pharmaceuticals
• Chongqing Shenghuaxi Pharm
• Tianjin Institute of Pharmaceutical Research
• Hainan Helpson Medicine & Biotechnique
• Disha Pharmaceutical Group
• Zhejiang Yongning Pharmaceutical
• Sihuan Pharmaceutical
• The United Laboratories Limited
• Guangzhou Baiyunshan Tianxin Pharmaceutical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Candesartan Cilexetil Tablets market?

What factors are driving Candesartan Cilexetil Tablets market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Candesartan Cilexetil Tablets market opportunities vary by end market size?

How does Candesartan Cilexetil Tablets break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Candesartan Cilexetil Tablets Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Candesartan Cilexetil Tablets by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Candesartan Cilexetil Tablets by Country/Region, 2020, 2024 & 2031
2.2 Candesartan Cilexetil Tablets Segment by Type
  2.2.1 4mg Tablets
  2.2.2 8mg Tablets
  2.2.3 16mg Tablets
  2.2.4 32mg Tablets
  2.2.5 Others
2.3 Candesartan Cilexetil Tablets Sales by Type
  2.3.1 Global Candesartan Cilexetil Tablets Sales Market Share by Type (2020-2025)
  2.3.2 Global Candesartan Cilexetil Tablets Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Candesartan Cilexetil Tablets Sale Price by Type (2020-2025)
2.4 Candesartan Cilexetil Tablets Segment by Application
  2.4.1 Essential Hypertension
  2.4.2 Others
2.5 Candesartan Cilexetil Tablets Sales by Application
  2.5.1 Global Candesartan Cilexetil Tablets Sale Market Share by Application (2020-2025)
  2.5.2 Global Candesartan Cilexetil Tablets Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Candesartan Cilexetil Tablets Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Candesartan Cilexetil Tablets Breakdown Data by Company
  3.1.1 Global Candesartan Cilexetil Tablets Annual Sales by Company (2020-2025)
  3.1.2 Global Candesartan Cilexetil Tablets Sales Market Share by Company (2020-2025)
3.2 Global Candesartan Cilexetil Tablets Annual Revenue by Company (2020-2025)
  3.2.1 Global Candesartan Cilexetil Tablets Revenue by Company (2020-2025)
  3.2.2 Global Candesartan Cilexetil Tablets Revenue Market Share by Company (2020-2025)
3.3 Global Candesartan Cilexetil Tablets Sale Price by Company
3.4 Key Manufacturers Candesartan Cilexetil Tablets Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Candesartan Cilexetil Tablets Product Location Distribution
  3.4.2 Players Candesartan Cilexetil Tablets Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR CANDESARTAN CILEXETIL TABLETS BY GEOGRAPHIC REGION

4.1 World Historic Candesartan Cilexetil Tablets Market Size by Geographic Region (2020-2025)
  4.1.1 Global Candesartan Cilexetil Tablets Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Candesartan Cilexetil Tablets Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Candesartan Cilexetil Tablets Market Size by Country/Region (2020-2025)
  4.2.1 Global Candesartan Cilexetil Tablets Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Candesartan Cilexetil Tablets Annual Revenue by Country/Region (2020-2025)
4.3 Americas Candesartan Cilexetil Tablets Sales Growth
4.4 APAC Candesartan Cilexetil Tablets Sales Growth
4.5 Europe Candesartan Cilexetil Tablets Sales Growth
4.6 Middle East & Africa Candesartan Cilexetil Tablets Sales Growth

5 AMERICAS

5.1 Americas Candesartan Cilexetil Tablets Sales by Country
  5.1.1 Americas Candesartan Cilexetil Tablets Sales by Country (2020-2025)
  5.1.2 Americas Candesartan Cilexetil Tablets Revenue by Country (2020-2025)
5.2 Americas Candesartan Cilexetil Tablets Sales by Type (2020-2025)
5.3 Americas Candesartan Cilexetil Tablets Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Candesartan Cilexetil Tablets Sales by Region
  6.1.1 APAC Candesartan Cilexetil Tablets Sales by Region (2020-2025)
  6.1.2 APAC Candesartan Cilexetil Tablets Revenue by Region (2020-2025)
6.2 APAC Candesartan Cilexetil Tablets Sales by Type (2020-2025)
6.3 APAC Candesartan Cilexetil Tablets Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Candesartan Cilexetil Tablets by Country
  7.1.1 Europe Candesartan Cilexetil Tablets Sales by Country (2020-2025)
  7.1.2 Europe Candesartan Cilexetil Tablets Revenue by Country (2020-2025)
7.2 Europe Candesartan Cilexetil Tablets Sales by Type (2020-2025)
7.3 Europe Candesartan Cilexetil Tablets Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Candesartan Cilexetil Tablets by Country
  8.1.1 Middle East & Africa Candesartan Cilexetil Tablets Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Candesartan Cilexetil Tablets Revenue by Country (2020-2025)
8.2 Middle East & Africa Candesartan Cilexetil Tablets Sales by Type (2020-2025)
8.3 Middle East & Africa Candesartan Cilexetil Tablets Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Candesartan Cilexetil Tablets
10.3 Manufacturing Process Analysis of Candesartan Cilexetil Tablets
10.4 Industry Chain Structure of Candesartan Cilexetil Tablets

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Candesartan Cilexetil Tablets Distributors
11.3 Candesartan Cilexetil Tablets Customer

12 WORLD FORECAST REVIEW FOR CANDESARTAN CILEXETIL TABLETS BY GEOGRAPHIC REGION

12.1 Global Candesartan Cilexetil Tablets Market Size Forecast by Region
  12.1.1 Global Candesartan Cilexetil Tablets Forecast by Region (2026-2031)
  12.1.2 Global Candesartan Cilexetil Tablets Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Candesartan Cilexetil Tablets Forecast by Type (2026-2031)
12.7 Global Candesartan Cilexetil Tablets Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Takeda
  13.1.1 Takeda Company Information
  13.1.2 Takeda Candesartan Cilexetil Tablets Product Portfolios and Specifications
  13.1.3 Takeda Candesartan Cilexetil Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Takeda Main Business Overview
  13.1.5 Takeda Latest Developments
13.2 Viatris (Mylan)
  13.2.1 Viatris (Mylan) Company Information
  13.2.2 Viatris (Mylan) Candesartan Cilexetil Tablets Product Portfolios and Specifications
  13.2.3 Viatris (Mylan) Candesartan Cilexetil Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Viatris (Mylan) Main Business Overview
  13.2.5 Viatris (Mylan) Latest Developments
13.3 Apotex
  13.3.1 Apotex Company Information
  13.3.2 Apotex Candesartan Cilexetil Tablets Product Portfolios and Specifications
  13.3.3 Apotex Candesartan Cilexetil Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Apotex Main Business Overview
  13.3.5 Apotex Latest Developments
13.4 AstraZeneca
  13.4.1 AstraZeneca Company Information
  13.4.2 AstraZeneca Candesartan Cilexetil Tablets Product Portfolios and Specifications
  13.4.3 AstraZeneca Candesartan Cilexetil Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 AstraZeneca Main Business Overview
  13.4.5 AstraZeneca Latest Developments
13.5 Alembic Pharmaceuticals
  13.5.1 Alembic Pharmaceuticals Company Information
  13.5.2 Alembic Pharmaceuticals Candesartan Cilexetil Tablets Product Portfolios and Specifications
  13.5.3 Alembic Pharmaceuticals Candesartan Cilexetil Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Alembic Pharmaceuticals Main Business Overview
  13.5.5 Alembic Pharmaceuticals Latest Developments
13.6 Zydus Lifesciences
  13.6.1 Zydus Lifesciences Company Information
  13.6.2 Zydus Lifesciences Candesartan Cilexetil Tablets Product Portfolios and Specifications
  13.6.3 Zydus Lifesciences Candesartan Cilexetil Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Zydus Lifesciences Main Business Overview
  13.6.5 Zydus Lifesciences Latest Developments
13.7 Cheplapharm Arzneimittel
  13.7.1 Cheplapharm Arzneimittel Company Information
  13.7.2 Cheplapharm Arzneimittel Candesartan Cilexetil Tablets Product Portfolios and Specifications
  13.7.3 Cheplapharm Arzneimittel Candesartan Cilexetil Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Cheplapharm Arzneimittel Main Business Overview
  13.7.5 Cheplapharm Arzneimittel Latest Developments
13.8 ANI Pharmaceuticals
  13.8.1 ANI Pharmaceuticals Company Information
  13.8.2 ANI Pharmaceuticals Candesartan Cilexetil Tablets Product Portfolios and Specifications
  13.8.3 ANI Pharmaceuticals Candesartan Cilexetil Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 ANI Pharmaceuticals Main Business Overview
  13.8.5 ANI Pharmaceuticals Latest Developments
13.9 Chongqing Shenghuaxi Pharm
  13.9.1 Chongqing Shenghuaxi Pharm Company Information
  13.9.2 Chongqing Shenghuaxi Pharm Candesartan Cilexetil Tablets Product Portfolios and Specifications
  13.9.3 Chongqing Shenghuaxi Pharm Candesartan Cilexetil Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
  13.9.4 Chongqing Shenghuaxi Pharm Main Business Overview
  13.9.5 Chongqing Shenghuaxi Pharm Latest Developments
13.10 Tianjin Institute of Pharmaceutical Research
  13.10.1 Tianjin Institute of Pharmaceutical Research Company Information
  13.10.2 Tianjin Institute of Pharmaceutical Research Candesartan Cilexetil Tablets Product Portfolios and Specifications
  13.10.3 Tianjin Institute of Pharmaceutical Research Candesartan Cilexetil Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
  13.10.4 Tianjin Institute of Pharmaceutical Research Main Business Overview
  13.10.5 Tianjin Institute of Pharmaceutical Research Latest Developments
13.11 Hainan Helpson Medicine & Biotechnique
  13.11.1 Hainan Helpson Medicine & Biotechnique Company Information
  13.11.2 Hainan Helpson Medicine & Biotechnique Candesartan Cilexetil Tablets Product Portfolios and Specifications
  13.11.3 Hainan Helpson Medicine & Biotechnique Candesartan Cilexetil Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
  13.11.4 Hainan Helpson Medicine & Biotechnique Main Business Overview
  13.11.5 Hainan Helpson Medicine & Biotechnique Latest Developments
13.12 Disha Pharmaceutical Group
  13.12.1 Disha Pharmaceutical Group Company Information
  13.12.2 Disha Pharmaceutical Group Candesartan Cilexetil Tablets Product Portfolios and Specifications
  13.12.3 Disha Pharmaceutical Group Candesartan Cilexetil Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
  13.12.4 Disha Pharmaceutical Group Main Business Overview
  13.12.5 Disha Pharmaceutical Group Latest Developments
13.13 Zhejiang Yongning Pharmaceutical
  13.13.1 Zhejiang Yongning Pharmaceutical Company Information
  13.13.2 Zhejiang Yongning Pharmaceutical Candesartan Cilexetil Tablets Product Portfolios and Specifications
  13.13.3 Zhejiang Yongning Pharmaceutical Candesartan Cilexetil Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
  13.13.4 Zhejiang Yongning Pharmaceutical Main Business Overview
  13.13.5 Zhejiang Yongning Pharmaceutical Latest Developments
13.14 Sihuan Pharmaceutical
  13.14.1 Sihuan Pharmaceutical Company Information
  13.14.2 Sihuan Pharmaceutical Candesartan Cilexetil Tablets Product Portfolios and Specifications
  13.14.3 Sihuan Pharmaceutical Candesartan Cilexetil Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
  13.14.4 Sihuan Pharmaceutical Main Business Overview
  13.14.5 Sihuan Pharmaceutical Latest Developments
13.15 The United Laboratories Limited
  13.15.1 The United Laboratories Limited Company Information
  13.15.2 The United Laboratories Limited Candesartan Cilexetil Tablets Product Portfolios and Specifications
  13.15.3 The United Laboratories Limited Candesartan Cilexetil Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
  13.15.4 The United Laboratories Limited Main Business Overview
  13.15.5 The United Laboratories Limited Latest Developments
13.16 Guangzhou Baiyunshan Tianxin Pharmaceutical
  13.16.1 Guangzhou Baiyunshan Tianxin Pharmaceutical Company Information
  13.16.2 Guangzhou Baiyunshan Tianxin Pharmaceutical Candesartan Cilexetil Tablets Product Portfolios and Specifications
  13.16.3 Guangzhou Baiyunshan Tianxin Pharmaceutical Candesartan Cilexetil Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
  13.16.4 Guangzhou Baiyunshan Tianxin Pharmaceutical Main Business Overview
  13.16.5 Guangzhou Baiyunshan Tianxin Pharmaceutical Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION


LIST OFTABLES

Table 1. Candesartan CilexetilTablets Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Candesartan CilexetilTablets Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 4mgTablets
Table 4. Major Players of 8mgTablets
Table 5. Major Players of 16mgTablets
Table 6. Major Players of 32mgTablets
Table 7. Major Players of Others
Table 8. Global Candesartan CilexetilTablets Sales byType (2020-2025) & (K Units)
Table 9. Global Candesartan CilexetilTablets Sales Market Share byType (2020-2025)
Table 10. Global Candesartan CilexetilTablets Revenue byType (2020-2025) & ($ million)
Table 11. Global Candesartan CilexetilTablets Revenue Market Share byType (2020-2025)
Table 12. Global Candesartan CilexetilTablets Sale Price byType (2020-2025) & (US$/Unit)
Table 13. Global Candesartan CilexetilTablets Sale by Application (2020-2025) & (K Units)
Table 14. Global Candesartan CilexetilTablets Sale Market Share by Application (2020-2025)
Table 15. Global Candesartan CilexetilTablets Revenue by Application (2020-2025) & ($ million)
Table 16. Global Candesartan CilexetilTablets Revenue Market Share by Application (2020-2025)
Table 17. Global Candesartan CilexetilTablets Sale Price by Application (2020-2025) & (US$/Unit)
Table 18. Global Candesartan CilexetilTablets Sales by Company (2020-2025) & (K Units)
Table 19. Global Candesartan CilexetilTablets Sales Market Share by Company (2020-2025)
Table 20. Global Candesartan CilexetilTablets Revenue by Company (2020-2025) & ($ millions)
Table 21. Global Candesartan CilexetilTablets Revenue Market Share by Company (2020-2025)
Table 22. Global Candesartan CilexetilTablets Sale Price by Company (2020-2025) & (US$/Unit)
Table 23. Key Manufacturers Candesartan CilexetilTablets Producing Area Distribution and Sales Area
Table 24. Players Candesartan CilexetilTablets Products Offered
Table 25. Candesartan CilexetilTablets Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Candesartan CilexetilTablets Sales by Geographic Region (2020-2025) & (K Units)
Table 29. Global Candesartan CilexetilTablets Sales Market Share Geographic Region (2020-2025)
Table 30. Global Candesartan CilexetilTablets Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global Candesartan CilexetilTablets Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global Candesartan CilexetilTablets Sales by Country/Region (2020-2025) & (K Units)
Table 33. Global Candesartan CilexetilTablets Sales Market Share by Country/Region (2020-2025)
Table 34. Global Candesartan CilexetilTablets Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global Candesartan CilexetilTablets Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas Candesartan CilexetilTablets Sales by Country (2020-2025) & (K Units)
Table 37. Americas Candesartan CilexetilTablets Sales Market Share by Country (2020-2025)
Table 38. Americas Candesartan CilexetilTablets Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas Candesartan CilexetilTablets Sales byType (2020-2025) & (K Units)
Table 40. Americas Candesartan CilexetilTablets Sales by Application (2020-2025) & (K Units)
Table 41. APAC Candesartan CilexetilTablets Sales by Region (2020-2025) & (K Units)
Table 42. APAC Candesartan CilexetilTablets Sales Market Share by Region (2020-2025)
Table 43. APAC Candesartan CilexetilTablets Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC Candesartan CilexetilTablets Sales byType (2020-2025) & (K Units)
Table 45. APAC Candesartan CilexetilTablets Sales by Application (2020-2025) & (K Units)
Table 46. Europe Candesartan CilexetilTablets Sales by Country (2020-2025) & (K Units)
Table 47. Europe Candesartan CilexetilTablets Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe Candesartan CilexetilTablets Sales byType (2020-2025) & (K Units)
Table 49. Europe Candesartan CilexetilTablets Sales by Application (2020-2025) & (K Units)
Table 50. Middle East & Africa Candesartan CilexetilTablets Sales by Country (2020-2025) & (K Units)
Table 51. Middle East & Africa Candesartan CilexetilTablets Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa Candesartan CilexetilTablets Sales byType (2020-2025) & (K Units)
Table 53. Middle East & Africa Candesartan CilexetilTablets Sales by Application (2020-2025) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Candesartan CilexetilTablets
Table 55. Key Market Challenges & Risks of Candesartan CilexetilTablets
Table 56. Key IndustryTrends of Candesartan CilexetilTablets
Table 57. Candesartan CilexetilTablets Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Candesartan CilexetilTablets Distributors List
Table 60. Candesartan CilexetilTablets Customer List
Table 61. Global Candesartan CilexetilTablets SalesForecast by Region (2026-2031) & (K Units)
Table 62. Global Candesartan CilexetilTablets RevenueForecast by Region (2026-2031) & ($ millions)
Table 63. Americas Candesartan CilexetilTablets SalesForecast by Country (2026-2031) & (K Units)
Table 64. Americas Candesartan CilexetilTablets Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 65. APAC Candesartan CilexetilTablets SalesForecast by Region (2026-2031) & (K Units)
Table 66. APAC Candesartan CilexetilTablets Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 67. Europe Candesartan CilexetilTablets SalesForecast by Country (2026-2031) & (K Units)
Table 68. Europe Candesartan CilexetilTablets RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa Candesartan CilexetilTablets SalesForecast by Country (2026-2031) & (K Units)
Table 70. Middle East & Africa Candesartan CilexetilTablets RevenueForecast by Country (2026-2031) & ($ millions)
Table 71. Global Candesartan CilexetilTablets SalesForecast byType (2026-2031) & (K Units)
Table 72. Global Candesartan CilexetilTablets RevenueForecast byType (2026-2031) & ($ millions)
Table 73. Global Candesartan CilexetilTablets SalesForecast by Application (2026-2031) & (K Units)
Table 74. Global Candesartan CilexetilTablets RevenueForecast by Application (2026-2031) & ($ millions)
Table 75.Takeda Basic Information, Candesartan CilexetilTablets Manufacturing Base, Sales Area and Its Competitors
Table 76.Takeda Candesartan CilexetilTablets Product Portfolios and Specifications
Table 77.Takeda Candesartan CilexetilTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78.Takeda Main Business
Table 79.Takeda Latest Developments
Table 80. Viatris (Mylan) Basic Information, Candesartan CilexetilTablets Manufacturing Base, Sales Area and Its Competitors
Table 81. Viatris (Mylan) Candesartan CilexetilTablets Product Portfolios and Specifications
Table 82. Viatris (Mylan) Candesartan CilexetilTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Viatris (Mylan) Main Business
Table 84. Viatris (Mylan) Latest Developments
Table 85. Apotex Basic Information, Candesartan CilexetilTablets Manufacturing Base, Sales Area and Its Competitors
Table 86. Apotex Candesartan CilexetilTablets Product Portfolios and Specifications
Table 87. Apotex Candesartan CilexetilTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Apotex Main Business
Table 89. Apotex Latest Developments
Table 90. AstraZeneca Basic Information, Candesartan CilexetilTablets Manufacturing Base, Sales Area and Its Competitors
Table 91. AstraZeneca Candesartan CilexetilTablets Product Portfolios and Specifications
Table 92. AstraZeneca Candesartan CilexetilTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. AstraZeneca Main Business
Table 94. AstraZeneca Latest Developments
Table 95. Alembic Pharmaceuticals Basic Information, Candesartan CilexetilTablets Manufacturing Base, Sales Area and Its Competitors
Table 96. Alembic Pharmaceuticals Candesartan CilexetilTablets Product Portfolios and Specifications
Table 97. Alembic Pharmaceuticals Candesartan CilexetilTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Alembic Pharmaceuticals Main Business
Table 99. Alembic Pharmaceuticals Latest Developments
Table 100. Zydus Lifesciences Basic Information, Candesartan CilexetilTablets Manufacturing Base, Sales Area and Its Competitors
Table 101. Zydus Lifesciences Candesartan CilexetilTablets Product Portfolios and Specifications
Table 102. Zydus Lifesciences Candesartan CilexetilTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Zydus Lifesciences Main Business
Table 104. Zydus Lifesciences Latest Developments
Table 105. Cheplapharm Arzneimittel Basic Information, Candesartan CilexetilTablets Manufacturing Base, Sales Area and Its Competitors
Table 106. Cheplapharm Arzneimittel Candesartan CilexetilTablets Product Portfolios and Specifications
Table 107. Cheplapharm Arzneimittel Candesartan CilexetilTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Cheplapharm Arzneimittel Main Business
Table 109. Cheplapharm Arzneimittel Latest Developments
Table 110. ANI Pharmaceuticals Basic Information, Candesartan CilexetilTablets Manufacturing Base, Sales Area and Its Competitors
Table 111. ANI Pharmaceuticals Candesartan CilexetilTablets Product Portfolios and Specifications
Table 112. ANI Pharmaceuticals Candesartan CilexetilTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. ANI Pharmaceuticals Main Business
Table 114. ANI Pharmaceuticals Latest Developments
Table 115. Chongqing Shenghuaxi Pharm Basic Information, Candesartan CilexetilTablets Manufacturing Base, Sales Area and Its Competitors
Table 116. Chongqing Shenghuaxi Pharm Candesartan CilexetilTablets Product Portfolios and Specifications
Table 117. Chongqing Shenghuaxi Pharm Candesartan CilexetilTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Chongqing Shenghuaxi Pharm Main Business
Table 119. Chongqing Shenghuaxi Pharm Latest Developments
Table 120.Tianjin Institute of Pharmaceutical Research Basic Information, Candesartan CilexetilTablets Manufacturing Base, Sales Area and Its Competitors
Table 121.Tianjin Institute of Pharmaceutical Research Candesartan CilexetilTablets Product Portfolios and Specifications
Table 122.Tianjin Institute of Pharmaceutical Research Candesartan CilexetilTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123.Tianjin Institute of Pharmaceutical Research Main Business
Table 124.Tianjin Institute of Pharmaceutical Research Latest Developments
Table 125. Hainan Helpson Medicine & Biotechnique Basic Information, Candesartan CilexetilTablets Manufacturing Base, Sales Area and Its Competitors
Table 126. Hainan Helpson Medicine & Biotechnique Candesartan CilexetilTablets Product Portfolios and Specifications
Table 127. Hainan Helpson Medicine & Biotechnique Candesartan CilexetilTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Hainan Helpson Medicine & Biotechnique Main Business
Table 129. Hainan Helpson Medicine & Biotechnique Latest Developments
Table 130. Disha Pharmaceutical Group Basic Information, Candesartan CilexetilTablets Manufacturing Base, Sales Area and Its Competitors
Table 131. Disha Pharmaceutical Group Candesartan CilexetilTablets Product Portfolios and Specifications
Table 132. Disha Pharmaceutical Group Candesartan CilexetilTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Disha Pharmaceutical Group Main Business
Table 134. Disha Pharmaceutical Group Latest Developments
Table 135. Zhejiang Yongning Pharmaceutical Basic Information, Candesartan CilexetilTablets Manufacturing Base, Sales Area and Its Competitors
Table 136. Zhejiang Yongning Pharmaceutical Candesartan CilexetilTablets Product Portfolios and Specifications
Table 137. Zhejiang Yongning Pharmaceutical Candesartan CilexetilTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Zhejiang Yongning Pharmaceutical Main Business
Table 139. Zhejiang Yongning Pharmaceutical Latest Developments
Table 140. Sihuan Pharmaceutical Basic Information, Candesartan CilexetilTablets Manufacturing Base, Sales Area and Its Competitors
Table 141. Sihuan Pharmaceutical Candesartan CilexetilTablets Product Portfolios and Specifications
Table 142. Sihuan Pharmaceutical Candesartan CilexetilTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Sihuan Pharmaceutical Main Business
Table 144. Sihuan Pharmaceutical Latest Developments
Table 145.The United Laboratories Limited Basic Information, Candesartan CilexetilTablets Manufacturing Base, Sales Area and Its Competitors
Table 146.The United Laboratories Limited Candesartan CilexetilTablets Product Portfolios and Specifications
Table 147.The United Laboratories Limited Candesartan CilexetilTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148.The United Laboratories Limited Main Business
Table 149.The United Laboratories Limited Latest Developments
Table 150. Guangzhou BaiyunshanTianxin Pharmaceutical Basic Information, Candesartan CilexetilTablets Manufacturing Base, Sales Area and Its Competitors
Table 151. Guangzhou BaiyunshanTianxin Pharmaceutical Candesartan CilexetilTablets Product Portfolios and Specifications
Table 152. Guangzhou BaiyunshanTianxin Pharmaceutical Candesartan CilexetilTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Guangzhou BaiyunshanTianxin Pharmaceutical Main Business
Table 154. Guangzhou BaiyunshanTianxin Pharmaceutical Latest Developments



LIST OFFIGURES

Figure 1. Picture of Candesartan CilexetilTablets
Figure 2. Candesartan CilexetilTablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Candesartan CilexetilTablets Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Candesartan CilexetilTablets Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Candesartan CilexetilTablets Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Candesartan CilexetilTablets Sales Market Share by Country/Region (2024)
Figure 10. Candesartan CilexetilTablets Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 4mgTablets
Figure 12. Product Picture of 8mgTablets
Figure 13. Product Picture of 16mgTablets
Figure 14. Product Picture of 32mgTablets
Figure 15. Product Picture of Others
Figure 16. Global Candesartan CilexetilTablets Sales Market Share byType in 2025
Figure 17. Global Candesartan CilexetilTablets Revenue Market Share byType (2020-2025)
Figure 18. Candesartan CilexetilTablets Consumed in Essential Hypertension
Figure 19. Global Candesartan CilexetilTablets Market: Essential Hypertension (2020-2025) & (K Units)
Figure 20. Candesartan CilexetilTablets Consumed in Others
Figure 21. Global Candesartan CilexetilTablets Market: Others (2020-2025) & (K Units)
Figure 22. Global Candesartan CilexetilTablets Sale Market Share by Application (2024)
Figure 23. Global Candesartan CilexetilTablets Revenue Market Share by Application in 2025
Figure 24. Candesartan CilexetilTablets Sales by Company in 2025 (K Units)
Figure 25. Global Candesartan CilexetilTablets Sales Market Share by Company in 2025
Figure 26. Candesartan CilexetilTablets Revenue by Company in 2025 ($ millions)
Figure 27. Global Candesartan CilexetilTablets Revenue Market Share by Company in 2025
Figure 28. Global Candesartan CilexetilTablets Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Candesartan CilexetilTablets Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Candesartan CilexetilTablets Sales 2020-2025 (K Units)
Figure 31. Americas Candesartan CilexetilTablets Revenue 2020-2025 ($ millions)
Figure 32. APAC Candesartan CilexetilTablets Sales 2020-2025 (K Units)
Figure 33. APAC Candesartan CilexetilTablets Revenue 2020-2025 ($ millions)
Figure 34. Europe Candesartan CilexetilTablets Sales 2020-2025 (K Units)
Figure 35. Europe Candesartan CilexetilTablets Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Candesartan CilexetilTablets Sales 2020-2025 (K Units)
Figure 37. Middle East & Africa Candesartan CilexetilTablets Revenue 2020-2025 ($ millions)
Figure 38. Americas Candesartan CilexetilTablets Sales Market Share by Country in 2025
Figure 39. Americas Candesartan CilexetilTablets Revenue Market Share by Country (2020-2025)
Figure 40. Americas Candesartan CilexetilTablets Sales Market Share byType (2020-2025)
Figure 41. Americas Candesartan CilexetilTablets Sales Market Share by Application (2020-2025)
Figure 42. United States Candesartan CilexetilTablets Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Candesartan CilexetilTablets Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Candesartan CilexetilTablets Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Candesartan CilexetilTablets Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Candesartan CilexetilTablets Sales Market Share by Region in 2025
Figure 47. APAC Candesartan CilexetilTablets Revenue Market Share by Region (2020-2025)
Figure 48. APAC Candesartan CilexetilTablets Sales Market Share byType (2020-2025)
Figure 49. APAC Candesartan CilexetilTablets Sales Market Share by Application (2020-2025)
Figure 50. China Candesartan CilexetilTablets Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Candesartan CilexetilTablets Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Candesartan CilexetilTablets Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Candesartan CilexetilTablets Revenue Growth 2020-2025 ($ millions)
Figure 54. India Candesartan CilexetilTablets Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Candesartan CilexetilTablets Revenue Growth 2020-2025 ($ millions)
Figure 56. ChinaTaiwan Candesartan CilexetilTablets Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Candesartan CilexetilTablets Sales Market Share by Country in 2025
Figure 58. Europe Candesartan CilexetilTablets Revenue Market Share by Country (2020-2025)
Figure 59. Europe Candesartan CilexetilTablets Sales Market Share byType (2020-2025)
Figure 60. Europe Candesartan CilexetilTablets Sales Market Share by Application (2020-2025)
Figure 61. Germany Candesartan CilexetilTablets Revenue Growth 2020-2025 ($ millions)
Figure 62.France Candesartan CilexetilTablets Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Candesartan CilexetilTablets Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Candesartan CilexetilTablets Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Candesartan CilexetilTablets Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Candesartan CilexetilTablets Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Candesartan CilexetilTablets Sales Market Share byType (2020-2025)
Figure 68. Middle East & Africa Candesartan CilexetilTablets Sales Market Share by Application (2020-2025)
Figure 69. Egypt Candesartan CilexetilTablets Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Candesartan CilexetilTablets Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Candesartan CilexetilTablets Revenue Growth 2020-2025 ($ millions)
Figure 72.Turkey Candesartan CilexetilTablets Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Candesartan CilexetilTablets Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Candesartan CilexetilTablets in 2025
Figure 75. Manufacturing Process Analysis of Candesartan CilexetilTablets
Figure 76. Industry Chain Structure of Candesartan CilexetilTablets
Figure 77. Channels of Distribution
Figure 78. Global Candesartan CilexetilTablets Sales MarketForecast by Region (2026-2031)
Figure 79. Global Candesartan CilexetilTablets Revenue Market ShareForecast by Region (2026-2031)
Figure 80. Global Candesartan CilexetilTablets Sales Market ShareForecast byType (2026-2031)
Figure 81. Global Candesartan CilexetilTablets Revenue Market ShareForecast byType (2026-2031)
Figure 82. Global Candesartan CilexetilTablets Sales Market ShareForecast by Application (2026-2031)
Figure 83. Global Candesartan CilexetilTablets Revenue Market ShareForecast by Application (2026-2031)